STUDY TO COMPARE SAFETY & EFFICACY OF ULTRASE MT20 IN CF

这个子项目是许多利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本研究的目的是获得关于Ultrase MT 20（一种已上市的胰酶）的安全性和有效性的信息。大约24人将参加这项研究项目在全国范围内，约两人将参加好时医疗中心。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research is to obtain information on the safety and effectiveness of Ultrase MT20, a pancreatic enzyme that is already on the market. Approximately 24 people will take part in this research project nationwide and about two people will take part at Hershey Medical Center.